The Essential Role of Lipopolysaccharide-binding Protein in Protection of Mice Against a Peritoneal Salmonella Infection Involves the Rapid Induction of an Inflammatory Response
Overview
Affiliations
Acute and chronic hyperinflammation are of major clinical concern, and many treatment strategies are therefore directed to inactivating parts of the inflammatory system. However, survival depends on responding quickly to pathogen attack, and since the adaptive immune system requires several days to adequately react, we rely initially on a range of innate defenses, many of which operate by activating parts of the inflammatory network. For example, LPS-binding protein (LBP) can transfer the LPS of Gram-negative bacteria to CD14 on the surface of macrophages, and this initiates an inflammatory reaction. However, the importance of this chain of events in infection is unclear. First, the innate system is redundant, and bacteria have many components that may serve as targets for it. Second, LBP can transfer LPS to other acceptors that do not induce inflammation. In this study, we show that innate defense against a lethal peritoneal infection with Salmonella requires a direct proinflammatory involvement of LBP, and that this is a major nonredundant function of LBP in this infection model. This emphasizes that blocking the LBP-initiated inflammatory cascade disables an essential defense pathway. Any anti-inflammatory protection that may be achieved must be balanced against the risks inherent in blinding the innate system to the presence of Gram-negative pathogens.
Uhde M, Indart A, Green P, Yolken R, Cook D, Shukla S Brain Behav Immun Health. 2023; 30:100627.
PMID: 37396339 PMC: 10308215. DOI: 10.1016/j.bbih.2023.100627.
Kazemi H, Najafi M, Ghasemian E, Rahimi-Mianji G, Pirsaraei Z J Genet. 2018; 97(4):843-851.
PMID: 30262696
Swaggerty C, Kogut M, He H, Genovese K, Johnson C, Arsenault R Front Vet Sci. 2018; 4:214.
PMID: 29322049 PMC: 5733560. DOI: 10.3389/fvets.2017.00214.
Divergence of protection induced by bacterial products and sepsis-induced immune suppression.
Sterns T, Pollak N, Echtenacher B, Mannel D Infect Immun. 2005; 73(8):4905-12.
PMID: 16041004 PMC: 1201202. DOI: 10.1128/IAI.73.8.4905-4912.2005.
Hamann L, Alexander C, Stamme C, Zahringer U, Schumann R Infect Immun. 2004; 73(1):193-200.
PMID: 15618154 PMC: 538978. DOI: 10.1128/IAI.73.1.193-200.2005.